Physician profile
Dena W Jackson
NPI 1477663318
$6,880.84
in general payments reported to CMS, 2019-2025
51 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $422 · 2021: $416 · 2022: $944 · 2023: $1,493 · 2024: $1,287 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,786.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $651.08 | 2019-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $630.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $628.28 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $482.80 | 2019-2025 | |
| Glaxosmithkline, LLC. | $468.45 | 2019-2025 | Trelegy Ellipta, Boostrix, Shingrix |
| Lilly USA, LLC | $377.16 | 2022-2025 | Mounjaro, Emgality, Reyvow |
| Abbvie INC. | $337.92 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $335.69 | 2019-2025 | Leqvio |
| Bayer Healthcare Pharmaceuticals INC. | $327.97 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $298.44 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $197.34 | 2019-2023 | Nuplazid |
| Janssen Pharmaceuticals, INC | $165.65 | 2019-2024 | Xarelto |
| Idorsia Pharmaceuticals US INC | $160.93 | 2022-2025 | Quviviq, Quviviq |
| Lundbeck LLC | $149.83 | 2023-2024 | Vyepti |
| Sunovion Pharmaceuticals INC. | $134.95 | 2019-2021 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.